Medicare Enrolled
Dr. Vernon Montoya, M.D.
Medical Oncology · Lake City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Montoya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Montoya? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Montoya
Dr. Vernon Montoya is a medical oncology in Lake City, FL, with 20 years in practice. Based on federal Medicare data, Dr. Montoya performed 65,426 Medicare services across 5,540 unique beneficiaries.
Between the years covered by Open Payments, Dr. Montoya received a total of $23,680 from 106 pharmaceutical and/or device companies across 1039 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Montoya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 32% volume in FL$ $23,680 industry payments
Medicare Practice Summary
Medicare Utilization ↗65,426
Medicare services
Top 32% in FL for medical oncology
5,540
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,271 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 27,000 | $1 | $5 |
| Iron infusion (Feraheme) | 22,950 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 5,640 | $19 | $73 |
| Complete blood count (CBC) with differential | 1,154 | $8 | $64 |
| Comprehensive metabolic blood panel | 1,126 | $10 | $87 |
| Blood draw (venipuncture) | 995 | $8 | $18 |
| Office visit, established patient (30-39 min) | 725 | $94 | $431 |
| Office visit, established patient (20-29 min) | 719 | $66 | $293 |
| Iron level test | 607 | $6 | $53 |
| Ferritin level test (iron stores) | 604 | $13 | $112 |
| Iron binding capacity test | 562 | $9 | $72 |
| Vitamin B-12 level test | 540 | $15 | $94 |
| Folic acid level test | 529 | $14 | $94 |
| Dexamethasone injection (steroid) | 270 | $0 | $1 |
| Hospital follow-up visit, high complexity | 221 | $96 | $592 |
| Anti-nausea injection (Aloxi/palonosetron) | 220 | $1 | $89 |
| Office visit, established patient, complex (40-54 min) | 215 | $138 | $576 |
| Drug injection, under skin or into muscle | 176 | $11 | $130 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 148 | $48 | $379 |
| New patient office visit, complex (60-74 min) | 130 | $167 | $806 |
| Lactate dehydrogenase (enzyme) level | 98 | $6 | $32 |
| Injection of additional new drug or substance into vein | 79 | $12 | $113 |
| Administration of chemotherapy into vein, 1 hour or less | 75 | $97 | $718 |
| Initial hospital admission, high complexity | 67 | $140 | $1,162 |
| Magnesium level test | 57 | $7 | $55 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 57 | $49 | $306 |
| Red blood count, automated test | 52 | $4 | $20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 50 | $133 | $1,298 |
| PSA test (prostate cancer screening) | 46 | $18 | $152 |
| Thyroid stimulating hormone (TSH) test | 43 | $16 | $135 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 42 | $1 | $9 |
| Testosterone (hormone) level, total | 39 | $25 | $121 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 33 | $26 | $164 |
| Administration of chemotherapy into vein, each additional hour | 32 | $22 | $154 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 30 | $22 | $160 |
| Drawing of blood for a medical problem | 29 | $70 | $309 |
| Carcinoembryonic antigen (cea) protein level | 24 | $19 | $156 |
| Phosphate level test | 23 | $5 | $39 |
| Office visit, established patient (10-19 min) | 19 | $42 | $256 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
76.6% high complexity
10.0% medium
13.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,680
Total received (2018-2024)
Avg $3,383/year across 7 years
Top 22% in FL for medical oncology
106
Companies
1,039
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,630 (74.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,024 (17.0%)
Other
Charitable contributions, space rental, and other categories
$1,371 (5.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$654 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,145
2023$3,343
2022$2,790
2021$3,669
2020$2,174
2019$6,398
2018$2,161
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$4,554
Novartis Pharmaceuticals Corporation
$2,340
AstraZeneca Pharmaceuticals LP
$1,149
PFIZER INC.
$1,127
E.R. Squibb & Sons, L.L.C.
$998
Amgen Inc.
$987
Janssen Biotech, Inc.
$803
Seagen Inc.
$684
Celgene Corporation
$629
Merck Sharp & Dohme LLC
$563
Exelixis Inc.
$534
Merck Sharp & Dohme Corporation
$485
Genentech USA, Inc.
$483
Astellas Pharma US Inc
$470
Lilly USA, LLC
$401
Daiichi Sankyo Inc.
$333
Takeda Pharmaceuticals U.S.A., Inc.
$314
Eisai Inc.
$304
Bayer HealthCare Pharmaceuticals Inc.
$304
NOVARTIS PHARMACEUTICALS CORPORATION
$263
Foundation Medicine, Inc.
$261
Regeneron Healthcare Solutions, Inc.
$256
GlaxoSmithKline, LLC.
$248
GENZYME CORPORATION
$245
EMD Serono, Inc.
$215
Octapharma USA, Inc.
$206
Gilead Sciences, Inc.
$180
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Ipsen Biopharmaceuticals, Inc
$142
Varian Medical Systems, Inc.
$138
Bayer Healthcare Pharmaceuticals Inc.
$137
EISAI INC.
$135
Pharmacyclics LLC, An AbbVie Company
$132
SERVIER PHARMACEUTICALS LLC
$128
BeiGene USA, Inc.
$127
Taiho Oncology, Inc.
$124
Stemline Therapeutics Inc.
$114
Sun Pharmaceutical Industries Inc.
$112
SOBI, INC
$102
PharmaEssentia USA Corporation
$101
ABBVIE INC.
$98
CTI BioPharma Corp.
$96
Agios Pharmaceuticals, Inc.
$94
Global Blood Therapeutics, Inc.
$92
Adaptive Biotechnologies Corporation
$91
AbbVie Inc.
$85
Seattle Genetics, Inc.
$78
ARRAY BIOPHARMA INC
$71
Alexion Pharmaceuticals, Inc.
$71
TESARO, Inc.
$70
TAIHO ONCOLOGY, INC.
$70
G1 Therapeutics, Inc.
$66
Blueprint Medicines Corporation
$63
SANOFI-AVENTIS U.S. LLC
$61
TerSera Therapeutics LLC
$60
Helsinn Therapeutics (U.S.), Inc.
$58
Pharmacosmos Therapeutics Inc.
$58
Horizon Therapeutics plc
$58
Kite Pharma, Inc.
$58
AbbVie, Inc.
$54
Kyowa Kirin, Inc.
$53
Servier Pharmaceuticals LLC
$51
Dendreon Pharmaceuticals LLC
$48
Pharmacyclics LLC, an AbbVie Company
$45
PUMA BIOTECHNOLOGY, INC.
$45
Elekta, Inc.
$44
Karyopharm Therapeutics Inc.
$43
MEDIVATION FIELD SOLUTIONS LLC
$42
Aveo Pharmaceuticals, Inc.
$42
Teva Pharmaceuticals USA, Inc.
$41
Aurobindo Pharma USA, Inc.
$40
Mirati Therapeutics, Inc.
$38
Blue Earth Diagnostics Limited
$35
Array BioPharma Inc.
$35
JAZZ PHARMACEUTICALS INC.
$34
Verity Pharmaceuticals Inc.
$32
Lexicon Pharmaceuticals, Inc.
$32
Janssen Scientific Affairs, LLC
$30
Janssen Pharmaceuticals, Inc
$30
AMAG Pharmaceuticals, Inc.
$30
RECORDATI_RARE_DISEASES_INC.
$29
Sirtex Medical Inc
$29
Rigel Pharmaceuticals, Inc.
$28
Clovis Oncology, Inc.
$25
AVEO Pharmaceuticals, Inc.
$22
R-Pharm US LLC
$22
Myriad Genetic Laboratories, Inc.
$21
Heron Therapeutics, Inc.
$20
ImmunoGen, Inc.
$20
EUSA Pharma (US) LLC
$19
Novocure Inc.
$18
Sobi, Inc
$17
GE HealthCare
$16
Shire North American Group Inc
$16
TG Therapeutics, Inc.
$16
Dova Pharmaceuticals
$15
INSYS Therapeutics Inc
$15
Coherus Biosciences Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Acceleron Pharma, Inc.
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Puma Biotechnology, Inc.
$13
Sysmex Inostics Inc
$12
Verastem, Inc.
$11
Secura Bio, Inc.
$10
SECURA BIO, INC.
$9
Top 3 companies account for 34.0% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELEKTA MEDICAL LINEAR ACCELERATOR · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · Erivedge · Erleada · FARYDAK · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GATTEX · GAVRETO · GAZYVA · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Onivyde · Optune · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · SYLVANT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · TrueBeam · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYKADIA · Zevalin · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $36 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
3
Per 100K population
4.2
County median income
$55,070
Nearest hospital
VA NORTH FLORIDA/SOUTH GEORGIA HEALTHCARE SYSTEM - LAKE CITY
9.9 mi
9.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Montoya is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Montoya experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Montoya performed 27,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Montoya receive payments from pharmaceutical companies?
Yes. Dr. Montoya received a total of $23,680 from 106 companies across 1,039 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Montoya's costs compare to other medical oncologys in Lake City?
Dr. Montoya's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Montoya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Lake City
Browse medical oncologys in Lake City ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology